iOmics
IOMICS is a Cambridge, Massachusetts-based AI company specializing in a fully automated Agentic AI platform called The Cures Accelerator™ for systems and synthetic biology, drug discovery, drug repurposing, and polypharmacology. Their platform integrates billions of scientific and clinical data points with automated machine learning, bioinformatics, computational chemistry, and network sciences to accelerate drug development and precision medicine research. IOMICS offers zero-cost customization, 24/7 technical and scientific support, and seamless interoperability with laboratory systems, aiming to provide actionable insights and hyper-speed collaboration in life sciences research. Their business model includes software products and consulting services, serving life science clients worldwide with a focus on accelerating cures through AI-driven discovery automation and technology services.
iOmics
IOMICS is a Cambridge, Massachusetts-based AI company specializing in a fully automated Agentic AI platform called The Cures Accelerator™ for systems and synthetic biology, drug discovery, drug repurposing, and polypharmacology. Their platform integrates billions of scientific and clinical data points with automated machine learning, bioinformatics, computational chemistry, and network sciences to accelerate drug development and precision medicine research. IOMICS offers zero-cost customization, 24/7 technical and scientific support, and seamless interoperability with laboratory systems, aiming to provide actionable insights and hyper-speed collaboration in life sciences research. Their business model includes software products and consulting services, serving life science clients worldwide with a focus on accelerating cures through AI-driven discovery automation and technology services.